Literature DB >> 9139214

[Cardiovascular risk factors in diabetic nephropathy].

J Zimmermann1, L Schramm, E Mulzer, E Heidbreder, H A Henrich, C Wanner.   

Abstract

BACKGROUND: Diabetic nephropathy is associated with increased cardiovascular mortality. This may be contributed to by changes in plasma lipids, fibrinogen and hemorheology. Cardiovascular autonomic dysfunction, which is related to an increased incidence of arrhythmic death, may also play a role. PATIENTS AND METHODS: Therefore, we investigated in 58 IDDM-patients with none (n = 28), incipient (albuminuria 30 to 300 mg/day, n = 11) and overt clinical nephropathy (albuminuria > 300 mg/day, n = 19) plasma concentrations of lipoproteins and fibrinogen, plasma viscosity, erythrocyte aggregation and erythrocyte rigidity. Assessments of neuropathy included tibial nerve motor conduction velocity, perception of vibration, beat-to-beat variation during rest and during forced respiration, heart-rate response to Valsalva maneuver and heart-rate response to standing (30:15).
RESULTS: Patients with clinical overt nephropathy had, compared to those without nephropathy, significantly higher concentrations of LDL-cholesterol, triglycerides and fibrinogen, significantly lower concentrations of HDL-cholesterol and significantly higher plasma viscosity, erythrocyte aggregability and erythrocyte rigidity. Regarding the assessments of neuropathy we found in patients with nephropathy, compared to those without nephropathy, significantly reduced tibial nerve motor conduction velocity, reduced perception of vibration thresholds and reduced heart rate variability during rest, during forced respiration, in response to Valsalva maneuver and in response to standing. In diabetic patients with microalbuminuria erythrocyte aggregability and erythrocyte rigidity were significantly higher and heart rate variability during rest was significantly lower than in patients without nephropathy.
CONCLUSION: In clinical overt nephropathy there is an aggregation of different cardiovascular risk factors, namely, disturbances in lipoprotein concentrations, increased fibrinogen concentration and disturbances in hemorheology. Furthermore marked deterioration in peripheral and autonomic cardial nerve function in these patients is evident accounting for a part of the greatly increased cardiovascular mortality of these patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9139214     DOI: 10.1007/bf03042288

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  23 in total

1.  Blood hyperviscosity and its relationship to progressive renal failure in patients with diabetic nephropathy.

Authors:  M P Gordge; A Patel; R W Faint; P B Rylance; G H Neild
Journal:  Diabet Med       Date:  1990-12       Impact factor: 4.359

2.  Importance of cardiovascular autonomic dysfunction in IDDM subjects with diabetic nephropathy.

Authors:  E Zander; B Schulz; P Heinke; E Grimmberger; G Zander; H D Gottschling
Journal:  Diabetes Care       Date:  1989-04       Impact factor: 19.112

3.  Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion.

Authors:  T Jensen; S Stender; T Deckert
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

4.  Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients.

Authors:  D J Ewing; O Boland; J M Neilson; C G Cho; B F Clarke
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

5.  Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy.

Authors:  O Schnell; C M Kirsch; J Stemplinger; M Haslbeck; E Standl
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

6.  Comparative study of arterial disease in amputated lower limbs from diabetics and non-diabetics (with special reference to feet arteries).

Authors:  T M Ferrier
Journal:  Med J Aust       Date:  1967-01-07       Impact factor: 7.738

7.  Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors.

Authors:  T Jensen; K Borch-Johnsen; A Kofoed-Enevoldsen; T Deckert
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

8.  [Chronic intermittent urokinase therapy in therapy-refractory angina pectoris].

Authors:  M Leschke; H Höffken; W Motz; H Blanke; F Schöbel; B E Strauer
Journal:  Dtsch Med Wochenschr       Date:  1992-01-17       Impact factor: 0.628

9.  Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

Authors:  S G Thompson; J Kienast; S D Pyke; F Haverkate; J C van de Loo
Journal:  N Engl J Med       Date:  1995-03-09       Impact factor: 91.245

10.  Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.

Authors:  J W Yarnell; I A Baker; P M Sweetnam; D Bainton; J R O'Brien; P J Whitehead; P C Elwood
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

View more
  1 in total

1.  [Lipoproteins and diabetic nephropathy].

Authors:  T Bertsch; J Aufenanger
Journal:  Med Klin (Munich)       Date:  1998-01-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.